Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions
{{output}}
This article summarizes the current literature and documents new evidence concerning drug-drug interactions (DDI) stemming from pharmacogenomic and circadian rhythm determinants of therapies used to treat common cardiovascular diseases (CVD), such as atheroscl... ...
